An interesting study aimed to evaluate whether there is a pattern in relation to alterations in lipid metabolic pathways among the spectrum of TDP43 proteinopathies and their corresponding clinical phenotypes: ALS patients, sporadic FTLD, c9FTLD patients, and compared to healthy controls [89]. Here, TARDBP is linked to proteostasis deficiencies.